United States - Eyeonic

Bringing Hospital-Grade Glaucoma Detection to Any Connected Device

THE TECHNOLOGY POWERING OUR TESTS

Eyeonic is an AI-powered visual field testing platform that turns any standard computer or tablet into a sophisticated ophthalmic testing device. For telehealth providers, ophthalmology networks, and health systems across the United States, Eyeonic delivers accurate glaucoma screening and monitoring without the cost, bulk, or bottlenecks of conventional perimetry equipment. No specialist hardware. No scheduling constraints. Fully FDA-compliant.

Why Telehealth Providers Choose Eyeonic:

FDA-Compliant AI Eye Testing: Eyeonic has progressed through the FDA regulatory pathway and is available for clinical deployment in the United States, giving your organisation confidence to offer validated glaucoma screening as part of your telehealth service.
No Specialist Hardware: Eyeonic replaces expensive, clinic-bound perimetry equipment. Any patient with a connected computer or tablet can complete an accurate, supervised visual field test from any location.
Seamless EMR and Telehealth Integration: Visual field test results are captured digitally and structured for integration with existing EMR and telehealth platforms, supporting remote clinical review without additional workflow disruption.
AI-Powered Patient Monitoring: Machine learning models developed with Microsoft Azure analyse visual field data across visits and surface clinically significant changes for clinician review, supporting longitudinal glaucoma management at scale.

Our Online Vision Tests Available in the United States

Visual Field Test

Hospital-grade visual field testing for early detection and long-term monitoring of glaucoma and other progressive eye conditions, accessible on any computer or tablet from any location across the United States.

Learn About Visual Field Testing

Driving Vision Test

Clinically robust, supra-threshold binocular assessment designed to confirm whether a driver’s visual field meets US licensing and road safety standards.

View Driver Requirements

Pilot Vision Test

High-stakes monocular visual field assessment purpose-built for aviation medical certification requirements under FAA pilot licensing standards.

Explore Aviation Standards

Upcoming Events

Eyeonic regularly attends and presents at ophthalmology, digital health, and healthcare technology events worldwide. Upcoming appearances will be listed here — check back soon or get in touch to arrange a meeting with our team at an event near you.

Past Events

NHS ConfedExpo 2026

June 2026 · Manchester, United Kingdom

Eyeonic joined the UK’s largest health and care conference, meeting NHS leaders and digital health teams to explore how browser-based visual field testing can support glaucoma pathways across the NHS.

London Tech Week 2026

June 2026 · Olympia London, United Kingdom

Eyeonic exhibited at one of the world’s leading technology events, showcasing AI-powered visual field testing to investors, health technology partners, and the international digital health community.

ANDHealth × Austrade Digital Health Trade Mission

June 2026 · United Kingdom & European Union

Eyeonic took part in a digital health trade mission connecting Australian health technology companies with UK and EU health systems, regulators, and commercial partners — strengthening Eyeonic’s international expansion pathways.

Our Story

Discover the journey from a glaucoma clinic insight to a globally validated, FDA-compliant, cloud-based medical device — and how Eyeonic became a trusted partner in North American telehealth.

Read Our Story

Our Founder

Meet A/Prof Simon Skalicky, the glaucoma subspecialist ophthalmologist, clinical researcher, and software developer who built Eyeonic to solve a problem he witnessed firsthand in busy glaucoma clinics.

Meet The Founder

Our Research

Eyeonic’s accuracy and reliability have been validated through peer-reviewed research and recognised at international ophthalmology conferences. Explore the science that underpins our platform.

View Our Research